|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-9-17
|
|
pubmed:abstractText |
In patients with localized gastrointestinal stromal tumors, surgery remains the elective treatment. Nowadays, imatinib therapy has been standardized in advanced gastrointestinal stromal tumors, showing continuous improvements in progression-free and overall survival. A combination of imatinib therapy and surgery may also be effective in a subset of patients with metastatic or unresectable gastrointestinal stromal tumors. In this review, the authors analyzed the role of imatinib mesylate associated to surgery in unresectable and/or metastatic gastrointestinal stromal tumors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0300-8916
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
96
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
392-9
|
|
pubmed:meshHeading |
pubmed-meshheading:20845798-Antineoplastic Agents,
pubmed-meshheading:20845798-Chemotherapy, Adjuvant,
pubmed-meshheading:20845798-Controlled Clinical Trials as Topic,
pubmed-meshheading:20845798-Gastrointestinal Stromal Tumors,
pubmed-meshheading:20845798-Humans,
pubmed-meshheading:20845798-Piperazines,
pubmed-meshheading:20845798-Protein Kinase Inhibitors,
pubmed-meshheading:20845798-Pyrimidines,
pubmed-meshheading:20845798-Randomized Controlled Trials as Topic,
pubmed-meshheading:20845798-Treatment Outcome
|
|
pubmed:articleTitle |
Efficacy of surgery and imatinib mesylate in the treatment of advanced gastrointestinal stromal tumor: a systematic review.
|
|
pubmed:affiliation |
Department of General and Emergency Surgery, St. Maria Hospital, Terni, University of Perugia, Italy. cirocchiroberto@yahoo.it
|
|
pubmed:publicationType |
Journal Article,
Review,
Meta-Analysis
|
